TY - JOUR AU - Partridge, E. E. AU - Barnes, M. N. PY - 1999 DA - 1999// TI - Epithelial ovarian cancer: prevention, diagnosis, and treatment JO - CA Cancer J Clin VL - 49 UR - https://doi.org/10.3322/canjclin.49.5.297 DO - 10.3322/canjclin.49.5.297 ID - Partridge1999 ER - TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Xu, J. AU - Ward, E. PY - 2010 DA - 2010// TI - Cancer Statistics 2010 JO - CA Cancer J Clin VL - 60 UR - https://doi.org/10.3322/caac.20073 DO - 10.3322/caac.20073 ID - Jemal2010 ER - TY - JOUR AU - Bast, R. C. AU - Hennessy, B. AU - Mills, G. B. PY - 2009 DA - 2009// TI - The biology of ovarian cancer: new opportunities for translation JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2644 DO - 10.1038/nrc2644 ID - Bast2009 ER - TY - JOUR AU - Ozols, R. F. AU - Bookman, M. A. AU - Connolly, D. C. AU - Daly, M. B. AU - Godwin, A. K. AU - Schilder, R. J. PY - 2004 DA - 2004// TI - Focus on epithelial ovarian cancer JO - Cancer Cell VL - 5 UR - https://doi.org/10.1016/S1535-6108(04)00002-9 DO - 10.1016/S1535-6108(04)00002-9 ID - Ozols2004 ER - TY - JOUR AU - Cannistra, S. A. PY - 2004 DA - 2004// TI - Cancer of the ovary JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMra041842 DO - 10.1056/NEJMra041842 ID - Cannistra2004 ER - TY - JOUR AU - Chien, J. AU - Kuang, R. AU - Landen, C. AU - Shridhar, V. PY - 2013 DA - 2013// TI - Platinum-sensitive recurrence in ovarian cancer: the role of the tumor environment JO - Front Oncol VL - 3 UR - https://doi.org/10.3389/fonc.2013.00251 DO - 10.3389/fonc.2013.00251 ID - Chien2013 ER - TY - JOUR AU - Yin, B. W. AU - Lloyd, K. O. PY - 2001 DA - 2001// TI - Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin (Muc16) JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M103554200 DO - 10.1074/jbc.M103554200 ID - Yin2001 ER - TY - JOUR AU - Yin, B. W. AU - Dnistrian, A. AU - Lloyd, K. O. PY - 2002 DA - 2002// TI - Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene JO - Int J Cancer VL - 98 UR - https://doi.org/10.1002/ijc.10250 DO - 10.1002/ijc.10250 ID - Yin2002 ER - TY - JOUR AU - O’Brien, T. J. AU - Beard, J. B. AU - Underwood, L. J. AU - Shigemasa, K. PY - 2002 DA - 2002// TI - The CA125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure JO - Tumour Biol VL - 23 UR - https://doi.org/10.1159/000064032 DO - 10.1159/000064032 ID - O’Brien2002 ER - TY - JOUR AU - Canney, P. A. AU - Moore, M. AU - Wilkinson, P. M. AU - James, R. D. PY - 1984 DA - 1984// TI - Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker JO - Br J Cancer VL - 50 UR - https://doi.org/10.1038/bjc.1984.254 DO - 10.1038/bjc.1984.254 ID - Canney1984 ER - TY - JOUR AU - Vergote, I. B. AU - Bormer, O. P. AU - Abeler, V. M. PY - 1987 DA - 1987// TI - Evaluation of serum CA 125 levels in the monitoring of ovarian cancer JO - Am J Obstet Gynecol VL - 157 UR - https://doi.org/10.1016/S0002-9378(87)80352-6 DO - 10.1016/S0002-9378(87)80352-6 ID - Vergote1987 ER - TY - JOUR AU - Bast, R. C. AU - Klug, T. L. AU - St-John, E. AU - Jenison, E. AU - Niloff, J. M. AU - Lazarus, H. PY - 1983 DA - 1983// TI - A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer JO - N Engl J Med VL - 309 UR - https://doi.org/10.1056/NEJM198310133091503 DO - 10.1056/NEJM198310133091503 ID - Bast1983 ER - TY - STD TI - Rancourt C, Matte I, Lane D, Piché A. The role of MUC16 mucin (CA125) in the pathogenesis of ovarian cancer. Chapter 4 in Ovarian Cancer: Basic science perspective. INTECH open access publisher: Janeza Trdine 9, 51000 Rijeka, Croatia; 2012. ID - ref13 ER - TY - JOUR AU - Moore, R. G. AU - Miller, M. C. AU - DiSilvestro, P. AU - Landrum, L. M. AU - Gajewski, W. AU - Ball, J. J. PY - 2011 DA - 2011// TI - Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with pelvic mass JO - Obstet Gynecol VL - 118 UR - https://doi.org/10.1097/AOG.0b013e318224fce2 DO - 10.1097/AOG.0b013e318224fce2 ID - Moore2011 ER - TY - JOUR AU - Moore, R. G. AU - McMeekin, D. S. AU - Brown, A. K. AU - DiSilvestro, P. AU - Miller, M. C. AU - Allard, W. J. PY - 2009 DA - 2009// TI - A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with pelvic mass JO - Gynecol Oncol VL - 112 UR - https://doi.org/10.1016/j.ygyno.2008.08.031 DO - 10.1016/j.ygyno.2008.08.031 ID - Moore2009 ER - TY - JOUR AU - Molina, R. AU - Escudero, J. M. AU - Augé, J. M. AU - Filella, X. AU - Foj, L. AU - Torné, A. PY - 2011 DA - 2011// TI - HE4 a novel tumour marker for ovarian cancer: comparison with CA125 and ROMA algorithm in patients with genaecological diseases JO - Tumor Biol VL - 32 UR - https://doi.org/10.1007/s13277-011-0204-3 DO - 10.1007/s13277-011-0204-3 ID - Molina2011 ER - TY - JOUR AU - Felder, M. AU - Kapur, A. AU - Bosquet, J. G. AU - Horibata, S. AU - Heintz, J. AU - Albrecht, R. PY - 2014 DA - 2014// TI - MUC16 (CA125): tumor biomarker to cancer therapy, work in progress JO - Mol Cancer VL - 13 UR - https://doi.org/10.1186/1476-4598-13-129 DO - 10.1186/1476-4598-13-129 ID - Felder2014 ER - TY - JOUR AU - Hanahan, H. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Mantovani, A. AU - Allavena, P. AU - Sica, A. AU - Balkwill, F. PY - 2008 DA - 2008// TI - Cancer-related inflammation JO - Nature VL - 454 UR - https://doi.org/10.1038/nature07205 DO - 10.1038/nature07205 ID - Mantovani2008 ER - TY - JOUR AU - Lane, D. AU - Robert, V. AU - Grondin, R. AU - Rancourt, C. AU - Piché, A. PY - 2007 DA - 2007// TI - Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt in human ovarian carcinoma cells JO - Int J Cancer VL - 121 UR - https://doi.org/10.1002/ijc.22840 DO - 10.1002/ijc.22840 ID - Lane2007 ER - TY - JOUR AU - Lane, D. AU - Goncharenko-Khaider, N. AU - Rancourt, C. AU - Piché, A. PY - 2010 DA - 2010// TI - Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation JO - Oncogene VL - 29 UR - https://doi.org/10.1038/onc.2010.107 DO - 10.1038/onc.2010.107 ID - Lane2010 ER - TY - JOUR AU - Goncharenko-Khaider, N. AU - Matte, I. AU - Lane, D. AU - Rancourt, C. AU - Piché, A. PY - 2012 DA - 2012// TI - Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis JO - Mol Cancer VL - 11 UR - https://doi.org/10.1186/1476-4598-11-84 DO - 10.1186/1476-4598-11-84 ID - Goncharenko-Khaider2012 ER - TY - JOUR AU - Lane, D. AU - Matte, I. AU - Rancourt, C. AU - Piché, A. PY - 2010 DA - 2010// TI - The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer JO - J Ovarian Res VL - 3 UR - https://doi.org/10.1186/1757-2215-3-1 DO - 10.1186/1757-2215-3-1 ID - Lane2010 ER - TY - JOUR AU - Mills, G. B. AU - May, C. AU - McGill, M. AU - Roifman, C. M. AU - Mellors, A. PY - 1988 DA - 1988// TI - A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action JO - Cancer Res VL - 48 ID - Mills1988 ER - TY - JOUR AU - Mills, G. B. AU - May, C. AU - Hill, M. AU - Campbell, S. AU - Shaw, P. AU - Marks, A. PY - 1990 DA - 1990// TI - Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells JO - J Clin Invest VL - 86 UR - https://doi.org/10.1172/JCI114784 DO - 10.1172/JCI114784 ID - Mills1990 ER - TY - JOUR AU - Richardson, M. AU - Gunawan, J. AU - Hatton, M. W. AU - Seidlitz, E. AU - Hirte, H. W. AU - Singh, G. PY - 2002 DA - 2002// TI - Malignant ascites fluids (MAF), including ovarian cancer-associated MAF, contains angiostatin and other factor(s) which inhibit angiogenesis JO - Gynecol Oncol VL - 86 UR - https://doi.org/10.1006/gyno.2002.6760 DO - 10.1006/gyno.2002.6760 ID - Richardson2002 ER - TY - JOUR AU - Xu, Y. AU - Gaudette, D. C. AU - Boynton, J. D. AU - Frankel, A. AU - Fang, X. J. AU - Sharma, A. PY - 1995 DA - 1995// TI - Characterization of an ovarian cancer activating factor in ascites of ovarian cancer patients JO - Clin Cancer Res VL - 1 ID - Xu1995 ER - TY - JOUR AU - Yamada, T. AU - Sato, K. AU - Komachi, M. AU - Malchinkhuu, E. AU - Tobo, M. AU - Kimura, T. PY - 2004 DA - 2004// TI - Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1 JO - J Biol Chem VL - 279 UR - https://doi.org/10.1074/jbc.M308133200 DO - 10.1074/jbc.M308133200 ID - Yamada2004 ER - TY - JOUR AU - Giuntoli, R. L. AU - Webb, T. J. AU - Zoso, A. AU - Rogers, O. AU - Diaz-Montes, T. P. AU - Bristow, R. E. PY - 2009 DA - 2009// TI - Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity JO - Anticancer Res VL - 29 ID - Giuntoli2009 ER - TY - JOUR AU - Matte, I. AU - Lane, D. AU - Laplante, C. AU - Rancourt, C. AU - Piché, A. PY - 2012 DA - 2012// TI - Profiling of cytokines in human epithelial ovarian cancer ascites JO - Am J Cancer Res VL - 2 ID - Matte2012 ER - TY - JOUR AU - Lane, D. AU - Matte, I. AU - Piché, A. PY - 2011 DA - 2011// TI - Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients JO - BMC Cancer VL - 11 UR - https://doi.org/10.1186/1471-2407-11-210 DO - 10.1186/1471-2407-11-210 ID - Lane2011 ER - TY - JOUR AU - Shahzad, M. M. AU - Arevalo, J. M. AU - Armaiz-Pena, G. N. AU - Lu, C. AU - Stone, R. L. AU - Moreno-Smith, M. PY - 2010 DA - 2010// TI - Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis JO - J Biol Chem VL - 285 UR - https://doi.org/10.1074/jbc.M110.109579 DO - 10.1074/jbc.M110.109579 ID - Shahzad2010 ER - TY - JOUR AU - Johnson, M. T. AU - Gotlieb, W. H. AU - Rabbi, M. AU - Martinez-Maza, O. AU - Berek, J. S. PY - 1993 DA - 1993// TI - Induction of cisplatin resistance and metallothionein expression by interleukin-6 JO - Gynecol Oncol VL - 49 ID - Johnson1993 ER - TY - JOUR AU - Cohen, S. AU - Bruuchim, I. AU - Graiver, D. AU - Evron, Z. AU - Oron-Karni, V. AU - Pasmanik-Chor, M. PY - 2013 DA - 2013// TI - Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2 JO - J Mol Med VL - 91 UR - https://doi.org/10.1007/s00109-012-0946-4 DO - 10.1007/s00109-012-0946-4 ID - Cohen2013 ER - TY - JOUR AU - Coward, J. I. AU - Kulbe, H. PY - 2012 DA - 2012// TI - The role of interleukin-6 in gynaecological malignancies JO - Cytokine Growth Factor Rev VL - 23 UR - https://doi.org/10.1016/j.cytogfr.2012.08.005 DO - 10.1016/j.cytogfr.2012.08.005 ID - Coward2012 ER - TY - JOUR AU - Hanash, S. M. AU - Pitteri, S. AU - Faca, V. M. PY - 2008 DA - 2008// TI - Mining the plasma proteome for cancer biomarker JO - Nature VL - 452 UR - https://doi.org/10.1038/nature06916 DO - 10.1038/nature06916 ID - Hanash2008 ER - TY - JOUR AU - Rustin, G. J. AU - Timmers, P. AU - Nelstrop, A. AU - Shreeves, G. AU - Bentzen, S. M. AU - Baron, B. PY - 2006 DA - 2006// TI - Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.01.2757 DO - 10.1200/JCO.2005.01.2757 ID - Rustin2006 ER - TY - JOUR AU - Lane, D. AU - Matte, I. AU - Rancourt, C. AU - Piché, A. PY - 2012 DA - 2012// TI - Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis JO - J Ovarian Res VL - 5 UR - https://doi.org/10.1186/1757-2215-5-34 DO - 10.1186/1757-2215-5-34 ID - Lane2012 ER - TY - JOUR AU - Lane, D. AU - Matte, I. AU - Laplante, C. AU - Garde-Granger, P. AU - Rancourt, C. AU - Piché, A. PY - 2013 DA - 2013// TI - Osteoprotegerin (OPG) activates integrin, focal adhesion knase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis JO - J Ovarian Res VL - 6 UR - https://doi.org/10.1186/1757-2215-6-82 DO - 10.1186/1757-2215-6-82 ID - Lane2013 ER - TY - JOUR AU - Duan, Z. AU - Foster, R. AU - Bell, D. A. AU - Mahoney, J. AU - Wolak, K. AU - Vaidya, A. PY - 2006 DA - 2006// TI - Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0861 DO - 10.1158/1078-0432.CCR-06-0861 ID - Duan2006 ER - TY - JOUR AU - Guo, Y. AU - Nemeth, J. AU - O’Brien, C. AU - Susa, M. AU - Liu, X. AU - Zhang, Z. PY - 2010 DA - 2010// TI - Effects of siltuximab on the IL-6-induced signaling pathway in ovarian cancer JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-1095 DO - 10.1158/1078-0432.CCR-10-1095 ID - Guo2010 ER - TY - JOUR AU - Yan, H. Q. AU - Huang, X. B. AU - Ke, S. Z. AU - Jiang, Y. N. AU - Zhang, Y. H. AU - Wang, Y. N. PY - 2014 DA - 2014// TI - Interleukin-6 augments lung cancer chemotherapeutic resistance via ataxia-telangiectasia mutated/NF-kappaB pathway activation JO - Cancer Sci VL - 105 UR - https://doi.org/10.1111/cas.12478 DO - 10.1111/cas.12478 ID - Yan2014 ER - TY - JOUR AU - Zeng, L. AU - O’Connor, C. AU - Zhang, J. AU - Kaplan, A. M. AU - Cohen, D. A. PY - 2010 DA - 2010// TI - IL-10 promotes resistance to apoptosis and metastatic potential in tumor lung tumor cell lines JO - Cytokine VL - 49 UR - https://doi.org/10.1016/j.cyto.2009.11.015 DO - 10.1016/j.cyto.2009.11.015 ID - Zeng2010 ER - TY - JOUR AU - Efferth, T. AU - Fabry, U. AU - Osieka, R. PY - 2000 DA - 2000// TI - Leptin contributes to the protection of human leukemic cells from cisplatinum cytotoxicity JO - Anticancer Res VL - 20 ID - Efferth2000 ER - TY - JOUR AU - Alfano, D. AU - Iaccarino, I. AU - Stoppelli, M. P. PY - 2006 DA - 2006// TI - Urokinase signaling through its receptor protects against anoikis by increasing Bcl-xL expression levels JO - J Biol Chem VL - 281 UR - https://doi.org/10.1074/jbc.M601812200 DO - 10.1074/jbc.M601812200 ID - Alfano2006 ER - TY - JOUR AU - Gutova, M. AU - Najbauer, J. AU - Gevorgyan, A. AU - Metz, M. Z. AU - Weng, Y. AU - Shih, C. C. PY - 2007 DA - 2007// TI - Identification of uPAR-positive chemoresistant cells in small cell lung cancer JO - PLoS ONE VL - 2 UR - https://doi.org/10.1371/journal.pone.0000243 DO - 10.1371/journal.pone.0000243 ID - Gutova2007 ER - TY - JOUR AU - Lambeck, A. J. AU - Crijns, A. P. AU - Leffers, N. AU - Sluiter, W. J. AU - Hoor, K. A. AU - Braid, M. PY - 2007 DA - 2007// TI - Serum cytokine profiling as a diagnostic and prognostic tool in ovarian cancer: a potential role for interleukin-7 JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-1828 DO - 10.1158/1078-0432.CCR-06-1828 ID - Lambeck2007 ER - TY - JOUR AU - Mustea, A. AU - Konsgen, D. AU - Braicu, E. I. AU - Pirvulescu, C. AU - Sun, P. AU - Sofroni, D. PY - 2006 DA - 2006// TI - Expression of IL-10 in patients with ovarian carcinoma JO - Anticancer Res VL - 26 ID - Mustea2006 ER - TY - JOUR AU - Chudecka-Glaz, A. M. AU - Cymbaluk-Ploska, A. A. AU - Menkiszak, J. L. AU - Pius-Sadowska, E. AU - Machalinski, B. B. AU - Sompolska-Rzechula, A. PY - 2015 DA - 2015// TI - Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions JO - OncoTargets Ther VL - 8 UR - https://doi.org/10.2147/OTT.S73438 DO - 10.2147/OTT.S73438 ID - Chudecka-Glaz2015 ER - TY - JOUR AU - Einhorn, N. AU - Knapp, R. C. AU - Bast, R. C. AU - Zurawski, V. R. PY - 1989 DA - 1989// TI - CA125 assay used in conjunction with CA 15–3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovary JO - Acta Oncol VL - 28 UR - https://doi.org/10.3109/02841868909092288 DO - 10.3109/02841868909092288 ID - Einhorn1989 ER - TY - JOUR AU - Scambia, G. AU - Testa, U. AU - Panici, P. B. AU - Foti, E. AU - Martucci, R. AU - Gadducci, A. PY - 1995 DA - 1995// TI - Prognostic significance of IL-6 serum levels in patients with ovarian cancer JO - Br J Cancer VL - 71 UR - https://doi.org/10.1038/bjc.1995.71 DO - 10.1038/bjc.1995.71 ID - Scambia1995 ER - TY - JOUR AU - Plante, M. AU - Rubin, S. C. AU - Wong, G. Y. AU - Federici, M. G. AU - Finstad, C. L. AU - Gastl, G. A. PY - 1994 DA - 1994// TI - Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer JO - Cancer VL - 73 UR - https://doi.org/3.0.CO;2-R DO - 3.0.CO;2-R ID - Plante1994 ER - TY - JOUR AU - Borsellino, N. AU - Belldegrun, A. AU - Bonavida, B. PY - 1995 DA - 1995// TI - Endogenous interleukin-6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines JO - Cancer Res VL - 55 ID - Borsellino1995 ER - TY - JOUR AU - Spriggs, D. PY - 2003 DA - 2003// TI - Optimal sequencing in the treatment of recurrent ovarian cancer JO - Gynecol Oncol VL - 90 ID - Spriggs2003 ER - TY - JOUR AU - Huang, H. AU - Li, Y. AU - Liu, J. AU - Zheng, M. AU - Feng, Y. AU - Hu, K. PY - 2012 DA - 2012// TI - Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0051256 DO - 10.1371/journal.pone.0051256 ID - Huang2012 ER - TY - JOUR AU - Han, Y. AU - Huang, H. AU - Xiao, Z. AU - Zhang, W. AU - Cao, Y. AU - Qu, L. PY - 2012 DA - 2012// TI - Integrated analysis of gene expression profiles associated with response of platinum/paclitaxel-based treatment in epithelial ovarian cancer JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0052745 DO - 10.1371/journal.pone.0052745 ID - Han2012 ER - TY - JOUR AU - Bachvarov, D. AU - L’Esperance, S. AU - Popa, I. AU - Bachvarova, M. AU - Plante, M. AU - Têtu, B. PY - 2006 DA - 2006// TI - Gene expression patterns of chemoresistant and chemosenstive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy JO - Int J Oncol VL - 29 ID - Bachvarov2006 ER - TY - JOUR AU - Weijl, N. I. AU - Hopman, G. D. AU - Wipkink-Bakker, A. AU - Lentjes, E. G. AU - Berger, H. M. AU - Cleton, F. J. PY - 1998 DA - 1998// TI - Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients JO - Ann Oncol VL - 9 UR - https://doi.org/10.1023/A:1008407014084 DO - 10.1023/A:1008407014084 ID - Weijl1998 ER - TY - JOUR AU - Lakshmanan, I. AU - Ponnusamy, M. P. AU - Das, S. AU - Chakraborty, S. AU - Haridas, D. AU - Mukhopadhyay, P. PY - 2012 DA - 2012// TI - MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.297 DO - 10.1038/onc.2011.297 ID - Lakshmanan2012 ER - TY - JOUR AU - Matte, I. AU - Lane, D. AU - Boivin, M. AU - Rancourt, C. AU - Piché, A. PY - 2014 DA - 2014// TI - MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-234 DO - 10.1186/1471-2407-14-234 ID - Matte2014 ER - TY - JOUR AU - Boivin, M. AU - Lane, D. AU - Rancourt, C. AU - Piché, A. PY - 2009 DA - 2009// TI - CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis JO - Gynecol Oncol VL - 115 UR - https://doi.org/10.1016/j.ygyno.2009.08.007 DO - 10.1016/j.ygyno.2009.08.007 ID - Boivin2009 ER - TY - JOUR AU - Chen, C. AU - Chang, Y. C. AU - Lan, M. S. AU - Breslin, M. PY - 2013 DA - 2013// TI - Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by incresing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways JO - Int J Oncol VL - 42 ID - Chen2013 ER -